• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米等离子体生物传感器:检测和放大循环肿瘤 DNA 的双重生物标志物。

Nanoplasmonic biosensor: detection and amplification of dual bio-signatures of circulating tumor DNA.

机构信息

Department of Chemical and Biological Engineering, College of Engineering, Korea University, Seoul 136-701, Republic of Korea.

Department of Chemical and Biological Engineering, College of Engineering, Korea University, Seoul 136-701, Republic of Korea.

出版信息

Biosens Bioelectron. 2015 May 15;67:443-9. doi: 10.1016/j.bios.2014.09.003. Epub 2014 Sep 6.

DOI:10.1016/j.bios.2014.09.003
PMID:25220802
Abstract

Circulating tumor DNA (ctDNA) bearing tumor-specific mutation and methylation are promising biomarkers for noninvasive cancer assessment. However, existing methods for ctDNA detection are restricted to genetic mutations. Recently, nanoplasmonics has emerged as a platform for one-step dual detection with high sensitivity and specificity. Here we present a strategy for ultrasensitive detection of tumor-specific mutations (E542K and E545K) and methylation of ctDNA of PIK3CA gene based on localized surface plasmon resonance (LSPR) and the coupling plasmon mode of gold nanoparticles (AuNPs). Peptide nucleic acids (PNA) is used as a probe to capture and enrich the 69-bp PIK3CA ctDNA. The exposure of PNA-probed AuNPs to 200 fM ctDNA generates LSPR-peak shift of 4.3 nm, corresponding to the primary response. Immunogold colloids are exploited as methylation detectors and plasmon coupling based enhancement for secondary response. LSPR-peak shifted from 4.3 nm to 11.4 nm upon the immunogold colloids binding to two methylcytosines (mCpG), which is an approximately 107% increase, compared to that of the primary response. This enhancement leads to four times (~50 fM) improvement of sensitivity and because of two mCpG sites, ctDNA was detected. These results demonstrate that the sensor can simultaneously detect the hot-spot mutation and epigenetic changes on the ctDNA. Promisingly, other specific-tumor mutants and epigenetic changes can be detected at low concentration with this platform.

摘要

循环肿瘤 DNA(ctDNA)携带肿瘤特异性突变和甲基化,是一种很有前途的非侵入性癌症评估生物标志物。然而,现有的 ctDNA 检测方法仅限于遗传突变。最近,纳米等离子体学作为一种具有高灵敏度和特异性的一步双检测平台已经出现。在这里,我们提出了一种基于局域表面等离子体共振(LSPR)和金纳米粒子(AuNPs)的耦合等离子体模式,用于超灵敏检测肿瘤特异性突变(E542K 和 E545K)和 PIK3CA 基因的 ctDNA 甲基化的策略。肽核酸(PNA)被用作探针来捕获和富集 69bp 的 PIK3CA ctDNA。当 PNA 探针 AuNPs 暴露于 200fM 的 ctDNA 时,会产生 4.3nm 的 LSPR 峰位移,对应于主要响应。免疫金胶体被用作甲基化探测器,并基于等离子体耦合进行二次响应的增强。当免疫金胶体结合到两个甲基胞嘧啶(mCpG)时,LSPR 峰从 4.3nm 移动到 11.4nm,相对于主要响应增加了约 107%。这种增强导致灵敏度提高了四倍(~50fM),因为有两个 mCpG 位点,所以可以检测到 ctDNA。这些结果表明,该传感器可以同时检测 ctDNA 上的热点突变和表观遗传变化。有希望的是,该平台可以以低浓度检测其他特定肿瘤突变体和表观遗传变化。

相似文献

1
Nanoplasmonic biosensor: detection and amplification of dual bio-signatures of circulating tumor DNA.纳米等离子体生物传感器:检测和放大循环肿瘤 DNA 的双重生物标志物。
Biosens Bioelectron. 2015 May 15;67:443-9. doi: 10.1016/j.bios.2014.09.003. Epub 2014 Sep 6.
2
Design of peptide nucleic acid probes on plasmonic gold nanorods for detection of circulating tumor DNA point mutations.基于等离子体金纳米棒的肽核酸探针设计用于检测循环肿瘤 DNA 点突变。
Biosens Bioelectron. 2019 Apr 1;130:236-244. doi: 10.1016/j.bios.2019.01.045. Epub 2019 Jan 29.
3
A dual biomarker detection platform for quantitating circulating tumor DNA (ctDNA).一种用于定量循环肿瘤DNA(ctDNA)的双生物标志物检测平台。
Nanotheranostics. 2018 Jan 1;2(1):12-20. doi: 10.7150/ntno.22419. eCollection 2018.
4
Distinct Rayleigh scattering from hot spot mutant p53 proteins reveals cancer cells.热斑点突变 p53 蛋白的独特瑞利散射揭示了癌细胞。
Small. 2014 Jul 23;10(14):2954-62. doi: 10.1002/smll.201400004. Epub 2014 Apr 3.
5
Nanoplasmonic biosensor: coupling electrochemistry to localized surface plasmon resonance spectroscopy on nanocup arrays.纳米等离子体生物传感器:在纳米杯阵列上将电化学与局域表面等离子体共振光谱学相结合。
Biosens Bioelectron. 2015 May 15;67:237-42. doi: 10.1016/j.bios.2014.08.022. Epub 2014 Aug 19.
6
Amplification of resonant Rayleigh light scattering response using immunogold colloids for detection of lysozyme.利用免疫胶体金放大共振瑞利光散射响应检测溶菌酶。
Small. 2013 Oct 25;9(20):3485-92. doi: 10.1002/smll.201202638. Epub 2013 Apr 19.
7
Single gold nanoplasmonic sensor for clinical cancer diagnosis based on specific interaction between nucleic acids and protein.基于核酸与蛋白质特异性相互作用的临床癌症诊断用单金纳米等离子体传感器
Biosens Bioelectron. 2015 May 15;67:59-65. doi: 10.1016/j.bios.2014.06.038. Epub 2014 Jun 24.
8
A versatile label-free electrochemical biosensor for circulating tumor DNA based on dual enzyme assisted multiple amplification strategy.一种基于双酶辅助多重扩增策略的循环肿瘤 DNA 的通用无标记电化学生物传感器。
Biosens Bioelectron. 2018 Dec 30;122:224-230. doi: 10.1016/j.bios.2018.09.028. Epub 2018 Sep 8.
9
Nanoplasmonic sensors for detecting circulating cancer biomarkers.用于检测循环肿瘤标志物的纳米等离子体传感器。
Adv Drug Deliv Rev. 2018 Feb 1;125:48-77. doi: 10.1016/j.addr.2017.12.004. Epub 2017 Dec 14.
10
A nanoplasmonic biosensor for label-free multiplex detection of cancer biomarkers.一种用于无标记多重检测癌症生物标志物的纳米等离子体生物传感器。
Biosens Bioelectron. 2015 Dec 15;74:341-6. doi: 10.1016/j.bios.2015.06.059. Epub 2015 Jun 30.

引用本文的文献

1
Towards Point-of-Care Single Biomolecule Detection Using Next Generation Portable Nanoplasmonic Biosensors: A Review.利用下一代便携式纳米等离子体生物传感器实现即时护理单生物分子检测综述
Biosensors (Basel). 2024 Dec 4;14(12):593. doi: 10.3390/bios14120593.
2
Recent advances in ctDNA detection using electrochemical biosensor for cancer.使用电化学生物传感器检测癌症患者循环肿瘤DNA的研究进展
Discov Oncol. 2024 Oct 2;15(1):517. doi: 10.1007/s12672-024-01365-7.
3
Emerging ctDNA detection strategies in clinical cancer theranostics.临床癌症诊疗中新兴的循环肿瘤DNA检测策略。
Smart Med. 2023 Nov 13;2(4):e20230031. doi: 10.1002/SMMD.20230031. eCollection 2023 Nov.
4
Circulating tumor DNA mutation analysis: advances in its application for early diagnosis of hepatocellular carcinoma and therapeutic efficacy monitoring.循环肿瘤 DNA 突变分析:在肝细胞癌早期诊断和疗效监测中的应用进展。
Aging (Albany NY). 2024 Jul 19;16(14):11460-11474. doi: 10.18632/aging.205980.
5
Recent Advancements in the Application of Circulating Tumor DNA as Biomarkers for Early Detection of Cancers.循环肿瘤 DNA 在癌症早期检测中作为生物标志物的应用的最新进展。
ACS Biomater Sci Eng. 2024 Aug 12;10(8):4740-4756. doi: 10.1021/acsbiomaterials.4c00606. Epub 2024 Jul 1.
6
Critical Issues on the Surface Functionalization of Plasmonic Au-Ag/TiO Thin Films with Thiolated Oligonucleotide-Based Biorecognition Elements.基于巯基化寡核苷酸生物识别元件的等离子体 Au-Ag/TiO 薄膜表面功能化的关键问题。
Biosensors (Basel). 2024 Mar 27;14(4):159. doi: 10.3390/bios14040159.
7
Nanobiotechnology augmented cancer stem cell guided management of cancer: liquid-biopsy, imaging, and treatment.纳米生物技术增强癌症干细胞指导下的癌症管理:液体活检、成像和治疗。
J Nanobiotechnology. 2024 Apr 12;22(1):176. doi: 10.1186/s12951-024-02432-5.
8
Optical nanomaterial-based detection of biomarkers in liquid biopsy.基于光学纳米材料的液体活检生物标志物检测。
J Hematol Oncol. 2024 Mar 14;17(1):10. doi: 10.1186/s13045-024-01531-y.
9
Advanced diagnostic and therapeutic strategies in nanotechnology for lung cancer.纳米技术在肺癌中的先进诊断与治疗策略
Front Oncol. 2022 Dec 7;12:1031000. doi: 10.3389/fonc.2022.1031000. eCollection 2022.
10
Electrochemical Biosensors for Circulating Tumor DNA Detection.用于循环肿瘤 DNA 检测的电化学生物传感器。
Biosensors (Basel). 2022 Aug 17;12(8):649. doi: 10.3390/bios12080649.